Heart structure and function in patients with generalized autoimmune diseases: Echocardiography with tissue Doppler study

Acta Cardiologica

Volumn 66, Issue 2, 2011, Pages 159-165

  Plazak, Wojciech ^a   Kopec, Grzegorz ^a   Tomkiewicz Pajak, Lidia ^a   Rubis, Pawel ^a   Dziedzic, Hanna ^a   Suchon, Elzbieta ^a   Kostkiewicz, Magdalena ^a   Olszowska, Maria ^a   Musial, Jacek ^b   Podolec, Piotr ^a  

^a Department of Cardiac and Vascular Diseases   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Autoimmune diseases; Dermato polymyositis; Echocardiography; Systemic lupus erythematosus; Systemic sclerosis; Tissue Doppler

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DIASTOLE; DIASTOLIC DYSFUNCTION; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLE; TISSUE DOPPLER IMAGING; TRICUSPID VALVE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMYOSITIS; SCLERODERMA, SYSTEMIC; SYSTOLE;

EID: 79955770948     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.2.2071246     Document Type: Article

References (40)

1. Smolen J, Weisman M. Connective tissue disorders. In: Hochberg M, Silman A, Smolen J, Weinblatt M, Weisman M, eds. Rheumatology. Mosby Elsevier, Philadelphia, 2008: 1205-85.
2. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Diseases of connective tissue. In: Braun-Falco O, ed. Dermatology. Springer-Verlag, Berlin, 2000: 789.
3. Plazak W, Zabinska-Plazak E, Wojas-Pelc A, Podolec P, Olszowska M, Tracz W, Bogdaszewska-Czabanowska J. Heart structure and function in systemic sclerosis. Eur J Dermatol 2002; 12: 257-62.
4. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-7.
5. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology 2006; 45(Suppl 4): iv18-21.
6. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14: 683-6.
7. Bruch C, Schmermund A, Bartel T, Schaar J, Erbel R. Tissue Doppler imaging: a new technique for assessment of pseudonormalization of the mitral inflow pattern. Echocardiography 2000; 17: 539-46.
8. Nagueh SF, Middleton K, Kopelen H, Zoghbi W, Quinones M. Doppler tissue imaging: a noninvasive technique for the evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-33.
9. Smith EL, Shmerling RH. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 1999; 8: 586-95.
10. Nanas S, Nanas J, Papazachou O, Kassiotis C, Papamichalopoulas A, Milic-Emili J, Roussos C. Resting lung function and hemodynamic parameters as predictors of exercise capacity in patients with chronic heart failure. Chest 2003; 123: 1386-93.
11. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008; 35: 458-65.
12. Kostis JB, Seibold JR, Turkevich D, Masi AT, Grau RG, Medsger TA, Stehen VD, Clements PJ, Szydlo L, D'Angelo WA. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988; 84: 1007-17.
13. Wynn J, Fineberg N, Matzer L, Cortada X, Armstrong W, Dillon JC, Kinney EL. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 1985; 110: 123-7.
14. Poanta L, Dadu R, Tiboc C, Rednic S, Dumitrascu D: Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med 2009; 20: 378-82.
15. Gaal J, Hegedus I, Devenyi K, Czirjak L. Myocardial gallinum-67 citrate scintigraphy in patients with systemic sclerosis. Ann Rheum Dis 1995; 54: 856-58.
16. Gustafsson R, Mannting F, Kazzam E, Waldenstrom A, Hallgren R. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989; 2: 475-9.
17. Hegedus I, Czirjak L. Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol 1995; 14: 161-4.
18. Ferri C, Emdin M, Giuggioli D, Carpeggiani C, Maielli M, Varga A, Michelassi C, Pasero G, L'Abbate A. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 1997; 36: 669-76.
19. Gurtner C, Werner RJ, Winten G, Krause BJ, Wendt T, Hor G, Holzmann H: Early diagnosis of cardiac involvement systemic sclerosis by 123I-MIBG neurotransmitter scintigraphy. Nucl Med Commun 1998; 19: 849-57.
20. Stollerman GH. Progressive systemic sclerosis (diffuse scleroderma). In: Braunwald E, ed. Heart disease. A Texbook of Cardiovascular Medicine. W.B. Saunders Company, Philadelphia, 1992: 1737.
21. Garcia-Fernandez MA, Azevedo J, Moreno M, Bermejo J, Perez-Castellano N, Puerta P, Desco M, Antoranz C, Serrano JA, Garcia E, Delcan JL. Regional diastolic function in ischemic heart disease using pulsed wave Doppler tissue imaging. Eur Heart J 1999; 20: 496-505.
22. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function. J Am Coll Cardiol 2006; 47: 76-84.
23. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haonzi A, Gong Y, Liu PP. Outcome of heart failure with preserved ejection fraction in a population-based study. New Engl J Med 2006; 355: 260-9.
24. Aurigemma P. Diastolic heart failure - a common and lethal condition by any name. N Engl J Med 2006; 355: 308-10.
25. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
26. Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Herve P, Raffestin B, Simmoneau G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995; 151: 384-9.
27. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement in systemic sclerosis. Lupus 2005; 14: 702-7.
28. Henein MY, Cailes J, O'Sullivan C, du Bois RM, Gibson DG. Abnormal ventricular long-axis function in systemic sclerosis. Chest 1995; 108: 1533-40.
29. Schattke S, Knebel F, Grohmann A, Dreger H, Kmezik F, Riemekasten G, Baumann G, Borges AC. Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler tissue and speckle tracking echocardiography study. Cardiovasc Ultrasound 2010; 8: 3.
30. Matias C, Isla LP, Vasconceleos M, Almeria C, Rodrigo JL, Serra V, Zamorano J. Speckle-tracking-derived strain and strain-rate analysis: a technique for the evaluation of early alterations in right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery pressure. J Cardiovasc Med 2009; 10: 129-34.
31. Vonk Noordegraaf A, Naeije R: Right ventricle function in scleroderma-related pulmonary hypertension. Rheumatology (Oxford) 2008; 47(suppl 5): v42-43.
32. Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009; 180: 881-6.
33. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65.
34. Weber KT, Sun Y, Tyagi SC, Cleutjens JP. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994; 26: 279-92.
35. Weber KT. Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation 1997; 96: 4065-82.
36. Sun Y, Zhang JQ, Zhang J, Ramires FJ. Angiotensin II, transforming growth factor b1 and repair in the infarcted heart. J Mol Cell Cardiol 1998; 30: 1559-69.
37. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771-9.
38. Targoff I. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 859-90.
39. Naarendorp M, Kerr LD, Khan AS, Ornstein MH. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol 1999; 26: 2257-60.
40. Sherer Y, Levy Y, Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 1999; 18: 238-40.